pharma · Hypertriglyceridemia · Asthma · GRCE
Grace Therapeutics
Grace Therapeutics clinical programs — 5 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 3009, boul. de la Concorde E., Suite 102, Laval, Québec H7E 2B5, CA
- Employees
- 18
- Programs
- 29
- Drugs
- 37
- Patents
- 34
Grace Therapeutics projects
5 ClinicalTrials.gov programs sponsored by Grace Therapeutics.
Grace Therapeutics has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
CaPre (TM)
Grace Therapeutics
Hypertriglyceridemia
1 trial -
Clonidine
Grace Therapeutics
Pregnancy Related
1 trial -
Eat Well Live Well Nutrition Program
Grace Therapeutics
Diabetes or Diabetes Prevention
1 trial -
Ketamine
Grace Therapeutics
Obstetric Pain
1 trial -
Lipid Lowering Medication
Grace Therapeutics
Hypertriglyceridemia
1 trial
Frequently asked questions
How many clinical projects does Grace Therapeutics have?
5 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.